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Abstract Metabolic modelling has entered a mature phase with dozens of methods
and software implementations available to the practitioner and the theoretician. It
is not easy for a modeller to be able to see the wood (or the forest) for the trees.
Driven by this analogy, we here present a “forest” of principal methods used for
constraint-based modelling in systems biology. This provides a tree-based view of
methods available to prospective modellers, also available in interactive version at
http://modellingmetabolism.net, where it will be kept updated with new methods
after the publication of the present manuscript. Our updated classification of existing
methods and tools highlights the most promising in the different branches, with the
aim to develop a vision of how existing methods could hybridise and become more
complex. We then provide the first hands-on tutorial for multi-objective optimisation
of metabolic models in R. We finally discuss the implementation of multi-view
machine-learning approaches in poly-omic integration. Throughout this work, we
demonstrate the optimisation of trade-offs between multiple metabolic objectives,
with a focus on omic data integration through machine learning. We anticipate that
the combination of a survey, a perspective on multi-view machine learning, and a
step-by-step R tutorial should be of interest for both the beginner and the advanced
user.
Introduction
Metabolism is the indispensable set of biochemical reactions in a cell that main-
tain its living state. Constraint-based reconstruction and analysis (COBRA) are a
group of techniques that are commonly used for the mathematical and computa-
tional modelling of metabolic networks at the whole-genome scale. Genome-scale
metabolic models are available in online repositories such as the Kyoto Encyclo-
pedia of Genes and Genomes (KEGG) [1], the Biochemical Genetic and Genomic
(BiGG) knowledge-base [2], the BioCyc collection of pathway/genome databases
[3], MetaNetX [4] and the ModelSEED database [5]. Principally, the preparation of a
genome-scale metabolic model involves the reconstruction of all metabolic reactions
taking place in the organism supplemented with functional annotation of genes,
metabolites and pathways. Depending on the quality of the reconstruction, processes
of manual curation and gap-filling may also be required [6]. Predictions obtained
from genome-scale metabolic models can be reconciled with in-vivo findings and
used to identify current gaps in our knowledge of metabolism [7].
There are often inconsistencies between models and experimental data, such as
when an outcome is falsely predicted by the model (false positive) or when an ex-
perimentally observed outcome is not predicted (false negative). Algorithms such
as Grow Match [8], SMILEY [9] and optimal metabolic network identification
(OMNI) [10] correct for such inconsistencies by suggesting adjustments for im-
proving model accuracy. Reducing disparity between predicted and experimentally
measured fluxes presents opportunities to devise new strategies for biological dis-
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covery [11]. GapFind and GapFill are jointly designed optimisation procedures to
identify ‘problem’ metabolites which cannot be produced or consumed in the network
and then propose mechanisms to restore pathway connectivity for these metabolites
[12]. fastGapFill is an extension of FASTCORE which incorporates flux and stoi-
chiometric consistency into the gap-filling process [13]. Metabolic reconstruction via
functional genomics (MIRAGE) conducts gap-filling by integrating with functional
genomics data to estimate the probability of including each reaction from a universal
database of gap-filling reactions in the reconstructed network [14]. This enables
selection of the set of reactions whose addition is most likely to result in a fully
functional model when flux analysis is repeated. Many models also integrate sig-
nalling and regulatory pathways with metabolic networks in order to add information
regarding underlying mechanisms, consequently improving flux predictions [15].
Here, we present the foundations of constraint-based metabolic modelling as well as
recent advances, in the form of a ‘forest’ of analytical tools and methods comprising
algorithms and their software implementations. As such techniques are likely to
expand and diversify over time, this schematic is also available in interactive version
at http://modellingmetabolism.net, where it will be updated as newer methods are
developed. We believe that classifying existing methods by their purpose or mode
of implementation and defining their strengths and limitations will greatly facilitate
the selection of methods for prospective modellers. In this regard, authors of new
tools and methods are invited to contact us in order to include these in the interactive
version of our figure.
In the following sections, we describe the main approaches currently used for
constraint-based metabolic modelling, with the inclusion of many recent devel-
opments which we consider to be significant. These methods are divided into un-
biased and biased approaches, the latter of which includes (i) a comprehensive
review of flux balance analysis (FBA) and its specific variants, which apply different
types of constraints for the prediction of metabolic fluxes (ii) regulatory methods,
for which constraints are derived from external sources for designing context- or
condition-specific metabolic models, and (iii) methods for the simulation of genetic
perturbations and selection of the objective function. Following this, a detailed discus-
sion of methods for performing multi-objective optimisation forms the basis of our
tutorial for genetic design by multi-objective optimisation (GDMO) in R. Finally, we
include a perspective that evaluates the potential use of multi-view machine learning
techniques for the analysis of multi-omic metabolic models, which we regard as an
important venture for the future of metabolic modelling.
Methods for constraint-based metabolic modelling
Figure 1 depicts the ‘forest’ of methods commonly used for constraint-based mod-
elling of metabolic networks, following and updating the framework proposed by
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Fig. 1 A forest of methods based on constraint-based reconstruction and analysis (COBRA).
Network-based pathway analysis describes the simplest configurations of metabolic pathways at
steady state. Monte Carlo methods allow for uniform sampling of the solution space to compute the
flux as a probability distribution for each pathway in the network. Thermodynamically infeasible
fluxes may be eliminated using loop removal or thermodynamic parameter-based analysis. Model
refinement may be carried out through the selection of single or multiple objectives or gap-filling
techniques. Gene perturbation helps to establish the essentiality of genes and the most efficient
pathways for the production of specific metabolites. Following this, strain design for metabolic
engineering may involve strategies for gene deletion, reaction perturbation, or reaction addition.
Alternate optimal solutions may be yielded by variations of flux balance analysis. Other variants
may specify the addition of specific constraints or their removal. Additional constraints may
be introduced through the inclusion of multi-omic data or gene regulatory mechanisms. Note
that some methods may belong to multiple categories, but for clarity we classify each method
according to its main contribution. An interactive version of this figure is maintained and updated at
http://modellingmetabolism.net.
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Lewis et al. [16]. Methodological approaches are broadly divided into biased and un-
biased; the former necessitates the definition of an objective function by the network,
whereas the latter relies on determining a subset of statistically analysable functional
states whilst searching the entirety of the solution space [17].
Unbiased methods
Unbiased methods search the entirety of the solution space and find a subset of statis-
tically analysable functional states without requiring the definition of an objective
function. Network-based pathway analysis comprises a large family of unbiased meth-
ods assessing the main properties of biochemical pathways [18]. Gene Association
Network-based Pathway Analysis (GANPA) improves upon this process by adding
gene weighting to determine gene non-equivalence within pathways [19]. Similarly,
a novel method was recently proposed for assessing the significance of pathways
by constructing weighted gene-gene interaction networks for normal and cancerous
tissue samples [20]. These interaction networks were subsequently used to expand
pathways for each set of samples and compare their topologies. Approaches based
on network-based pathway enrichment analysis aim to identify a greater number of
gene interactions. For example, NetPEA utilises a protein-protein interaction (PPI)
network combined with random walk to include information from high-throughput
networks as well as known pathways [21]. A combination of network estimation
with condition-specific omic data has been used to refine the NetGSA framework,
thereby improving the ability to detect differential activity in pathways [22].
Using network-based pathway analysis, different methods may be used to calculate
a set of routes through the reaction network and the corresponding kernel matrices
which represent their stoichiometry. Elementary flux modes (EFMs) describe the
minimal, non-decomposable set of pathways operating within a steady-state system;
these are found by solving the steady-state condition following the iterative removal
of single reactions until a valid flux distribution can no longer be calculated [23]. As
this process often yields a combinatorial explosion of common functional motifs, a
variation of the Agglomeration of Common Motifs (ACoM) method can be used to
cluster these motifs, allowing for an overlap between classes [24]. Alternatively, a sin-
gle EFM may be determined by solving an optimisation problem using EFMevolver
[25], which can draw attention to significant EFMs. A method known as K-shortest
EFMs enumerates EFMs in order of their number of reactions and has been applied
to genome-scale networks [26]; the shortest pathways are of interest as they typically
carry the highest flux and are easily manipulable.
A minimal generating set is the smallest set necessary to define the geometry of
the flux space using a null-space algorithm, the elements of which are known as
generating flux modes (GFMs) or minimal generators [27]. A variant of this method
can be used to find specific subsets of GFMs in a process which does not result in a
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combinatorial explosion, thus making them easier to compute [28]. Methods using
minimal descriptions of the flux cone, such as minimal generators [29] and minimal
metabolic behaviours [30] aim to reduce the dimensionality of the flux cone. A recent
method prioritises the search for the shortest path between a pair of end nodes based
on graph theory [31]. However, the validity of this approach has been questioned as
reaction stoichiometry is overlooked [32]. tEFMA [33] removes thermodynamically-
infeasible EFMs using network-embedded thermodynamic (NET) analysis [34]. The
incorporation of thermodynamic constraints helps to select for physiologically sig-
nificant EFMs, which become more difficult to detect as the size and complexity
of networks increases. Identifying the largest thermodynamically consistent sets
(LTCSs) in these EFMs can further characterise condition-specific metabolic capabil-
ities in the thermodynamically-feasible regions of the flux cone [35].
Extreme pathways can be described as being a systemically independent subset of
EFMs [18]. They are characterised by a set of convex basis vectors used to represent
the edges of the steady-state solution space and consist of the minimum number of
reactions needed to exist as a functional unit [36]. As opposed to many of methods
described previously, extreme currents aim to increase dimensionality by describing
non-decomposable EFMs situated both within and on the boundaries of the flux
regions; these arise as a result of partitioning each reversible reaction into two
irreversible reactions [37]. Minimal cut sets (MCSs) are another variant of EFMs
that result in inactivity of the system with respect to the objective reaction if removed
[38]. Therefore, they can be used to identify target genes and repress undesirable
metabolic functions, whilst assessing the effect on the structure of the entire metabolic
network. Elementary flux patterns (EFPs) define all potential elementary routes for
steady-state fluxes as sets of indices, and can be mapped to EFMs to include factors
such as pathway interdependencies, thus taking the entire network into account [39].
Frameworks which combine various computational approaches for synthetic pathway
prediction, such as GEM-Path [40] and BNICE [41] are increasing in number as they
provide the opportunity to calculate all possible paths and score them by efficiency
[42].
Unbiased methods may also incorporate Monte Carlo sampling, message passing
algorithms [43] or symbolic flux analysis [44]. The Markov chain Monte Carlo
(MCMC) method can be used to uniformly sample metabolic networks from a
genotype space, producing a sequence of viable genotypes (or reaction subsets) by
performing a reaction swap between each genotype and its successor; if a swap results
in a non-viable genotype, this sequence will remain at the previous genotype for that
step and the process is repeated until a metabolic network with the correct number
of reactions is reached [45]. A Monte Carlo based technique has also been used for
uniform sampling of feasible steady states in an ellipsoid representing the solution
space for a genome-scale metabolic model of Escherichia coli [46]. A revision of
this method was proposed with rounding procedures to improve performance by
eliminating ill-conditioning when sampling convex polytopes of steady states [47].
Of all omic data types, metabolomic data are said to give the closest indication of
observed phenotypes [48]. Therefore, extracellular metabolomic measurements can
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help to predict intracellular flux states by integrating these data into a constraint-based
framework using a sampling-based network approach [49, 50]. The MetaboTools
toolbox provides a workflow for integrating metabolomic data into multi-omic models
and predicting metabolic phenotypes through analysing how metabolite uptake and
secretion differ between conditions [48].
Biased methods
Biased methods rely on the definition of an objective function to solve the metabolic
network and find its flux rates. For instance, standard flux balance analysis belongs
to this class of methods.
Flux balance analysis and its variants
Among the biased methods, the most well-known technique is flux balance analysis
(FBA), which uses the assignment of stoichiometric coefficients in a matrix to
represent the metabolites involved in any given reaction in a metabolic network [51].
Through these coefficients, constraints can be imposed on the system to identify all
potential flux distributions associated with a corresponding set of feasible phenotypic
states. The aim of FBA is to locate a value (or set of values) in the solution space
that best satisfies a given objective function. FBA uses linear programming to solve
this objective function, indicating the extent to which each reaction in the network
contributes to a phenotypic state.
If two objectives (flux rates or linear combinations thereof) were to be maximised, a
multi-level linear problem would be formulated as follows:
max gᵀv
such that max f ᵀv
such that Sv= 0
vmin ≤ v≤ vmax
(1)
where f and g are n-dimensional arrays of weights associated with the first and second
objectives respectively, and indicate the contribution of the reaction fluxes v to each
objective. vmin and vmax are vectors representing the lower and upper limits for the
flux rates in v. A constraint in FBA postulates that the total amount of any metabolite
being produced must be equal to the total amount of that metabolite consumed [52].
The most common objective function computed by FBA is the synthesis of biomass,
which is commonly used to indicate cellular growth rate and predict product yields
[53]. Fluxes can either be calculated under the steady state assumption or in a dynamic
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state, where changes in specific concentrations and kinetics parameters have been
recorded for each metabolite over time (e.g. for DFBA) [54]. Experimental validation
of model predictions for DFBA are often obtained from 13C metabolic flux analysis
[55], which utilises isotopic-labelling of metabolic substrates to quantify intracellular
fluxes. Additionally, methods such as dynamic multi-species metabolic modelling
(DMMM) have been used to examine inter-species competition for metabolites in a
microbial community [56].
Numerous modifications of FBA propose the application of various constraints to
shrink the solution space for determining the precise flux state of the cell by calculat-
ing the optimal set of solutions for a given objective via linear programming. In most
instances, constraints are defined by cell and reaction stoichiometry, fluxes through
transport and metabolic reactions, upper and lower bounds for each flux, biomass
composition and ATP requirements [57]. Upper and lower bounds can be estimated
using flux variability analysis [58], which returns the maximum and minimum fluxes
through each reaction whilst maintaining minimal biomass production [59].
Linear thermodynamic constraints can be applied in thermodynamic metabolic flux
analysis (TMFA) (or thermodynamics-based flux balance analysis) and thermody-
namic variability analysis to eliminate thermodynamically infeasible reactions or
loops from pathways and gather information on feasible metabolite activity and Gibbs
free energy changes [60, 61]. The removal of thermodynamically infeasible loops
is necessary to prevent violating the loop law, which states that there is no net flux
through balanced biochemical loops in networks at steady state [62]. Loopless CO-
BRA methods solve a modified mixed-integer problem with the added constraint of
no network fluxes containing loops; application of this constraint has been described
for FBA, FVA and MCMC sampling [63]. FBA with thermodynamic constraints
has also been described in energy-balance analysis (EBA) [64]. Fast flux variability
analysis with thermodynamic constraints (tFVA) removes unbounded fluxes from bio-
chemical loops arising from non-zero, steady-state fluxes involving internal reactions
[65]. This is a faster implementation of FVA that does not require the specification
of metabolite concentrations or additional experimental data, although these have
been included in other variants of the method.
Parsimonious FBA (pFBA) identifies a subset of genes contributing to maximising the
growth rate in-silico, therefore enabling maximisation of stoichiometric efficiency
[66]. Another technique uses conditional dependencies present in the metabolic
model as constraints for each flux, whereby each flux is constrained by the activity
of the compound that facilitates it. This technique is known as conditional FBA and
has proved to be effective for simulating phototrophic growth and diurnal dynamics
in cyanobacteria [67, 68]. Resource balance analysis (RBA) uses growth rate limita-
tion caused by distribution of proteins between cellular processes to constrain flux
predictions [69]. Constrained allocation flux balance analysis (CAFBA) applies a
genome-wide constraint on fluxes to observe proteome allocation between ribosomal,
transport and biosynthetic proteins [70]. For this method, growth laws governing the
synthesis of intracellular proteins are used to design parameters for predicting levels
of protein expression and energy production. To improve the prediction of internal
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fluxes, cost reduced sub-optimal FBA (corsoFBA) minimises protein and thermo-
dynamic costs to simulate a sub-optimal state [71]. Linear metabolite dilution flux
balance analysis (limed-FBA) forces dilution in metabolites associated with growth
in active reactions, by adding a small dilution flux to block metabolic pathways
without input fluxes [72].
Although more time-consuming than a linear programming approach, Bayesian flux
estimation results in a probability density function, which is more stable and infor-
mative than a simple point estimate [73]. The METABOLICA statistical framework
utilises a Bayesian approach to performing FBA. Metabolism is modelled in a multi-
compartment macroscopic model with a stochastic extension of the stationary state
and the Bayesian inference problem is solved by computing posterior probability
densities using MCMC sampling [74].
Alternatively, standard constraints may be removed to construct new FBA methods
to improve flux predictions for non-steady-state or non-wild-type cells. Relaxing the
assumption of fixed reactant proportions for biomass production is the basis of flexible
FBA (flexFBA), which can be coupled with relaxing the fixed ratio of byproduct to
reactant (known as time-linked FBA) to observe transitions between steady states
[75]. Combining these methods also enables the comparison of metabolite production
between knockout mutants.
To further increase the informativity of constraint-based models, the integration of
information from regulatory pathways and external multi-omic data is described in
the following section.
Regulatory methods to generate context-specific metabolic models
Regulatory methods can be used to set constraints for FBA which incorporate reg-
ulatory networks, as well as introducing external omic data, which provides the
opportunity to simulate metabolism under specific genetic or environmental condi-
tions. Steady-state regulatory flux balance analysis (SR-FBA) is used to quantify
the extent to which metabolic and transcriptional regulatory constraints affect the
state of flux activity for various metabolic genes [76]. SR-FBA allows for improved
characterisation of steady-state metabolic behaviour compared to regulatory FBA
(rFBA), which chooses a single steady state per time interval from all possible solu-
tions to find the flux distribution consistent with the regulatory state of each interval.
Integrated FBA (iFBA) incorporates metabolic, regulatory and signalling pathways
in the FBA model to enable thorough characterisation of dynamic-state metabolic be-
haviour [77]. Integrated dynamic flux balance analysis (idFBA) additionally couples
fast and slow reactions to give quantitative time-variant flux predictions [78].
However, many of these approaches are limited by the Boolean logic formalism,
which restricts the definition of gene activity to an on/off state. This disadvantage
can be overcome by using conditional probabilities to represent gene states and
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gene-transcription factor interactions when combining high throughput data with
regulatory networks, as demonstrated by PROM [79]. This approach allows for
a greater number of interactions between metabolic models and their respective
transcriptional regulatory networks to be recorded as they are quantified automatically
[80]. Other methods take a differential (rather than absolute) approach to gene
expression analysis where gene expression levels classified as belonging to one of
three states: over-expressed, unchanged or under-expressed [32]. FlexFlux jointly
analyses multi-state regulatory networks and metabolic pathways, both of which
contribute to calculation of flux [81]. Upon constructing an initial regulatory network,
qualitative states evolving towards an ‘attractor’ set are converted into user-defined
continuous intervals, thus allowing reactions to be constrained by multiple flux values,
rather than one single value. The multi-formalism interaction network simulator
(MUFINS) provides a platform for combining multiple kinetic models with signalling
and regulatory networks, omic data integration algorithms and steady state FBA with
linear inhibitor and activator constraints [82]. In this method, a quasi-steady state
Petri net (QSSPN) is used to illustrate interactions between different networks [83].
Transcriptional-controlled FBA (tFBA) uses constraints between pairs of conditions
based on gene expression data for the optimisation of FBA, considering both fold
change and absolute change in expression to minimise noise [84]. Recently, a new
method called transcriptional regulated flux balance analysis (TRFBA) has been
introduced for incorporating expression data as well as transcriptional regulatory
networks to simulate growth under various environmental and genetic perturbations
[85]. TRFBA applies two unique linear constraints. Firstly, reaction rates are limited
using a constant that sets expression levels equal to the upper bounds of reactions;
secondly, the expression level of each gene is correlated with the expression of
the regulating genes. One important advantage of TRFBA is the ability to improve
predictions of growth without requiring detailed information about transcriptional
regulators and their target genes.
For the integration of transcriptomic profiles with metabolic networks, gene expres-
sion measurements can be obtained from microarray and/or RNA sequencing data
stored in public repositories such as the Gene Expression Omnibus (GEO) [86] or
Array Express [87], in order to examine gene activity across various conditions.
In addition to these primary archives, there are also databases with additional data
processing and annotation [88] (such as information regarding gene regulation or
differential expression under various conditions) e.g. Gene Expression Atlas [89], or
the web servers Gene Chaser [90] and Profile Chaser [91], which query GEO. There
are also many specialised databases providing functional genomic data relating to
a particular disease, species or tissue-type, such as Oncomine (for cancer-specific
microarrays) [92], the MGI Mouse Gene Expression Database (GXD) [93] or the Pan-
creatic Expression Database (PED) [94]. The generation of context-specific metabolic
models may be divided into two main approaches: switch-based and valve-based
methods.
Switch-based methods for omic integration. Switch-based algorithms remove in-
active or lowly expressed genes by setting the corresponding reaction boundaries to
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zero before FBA is performed [95]. For instance, the algorithm for gene inactivity
moderated by metabolism and expression (GIMME) finds a flux distribution which
optimises a given objective and avoids the use of so-called ‘inactive’ reactions below
a certain transcription threshold [96, 97]. The main advantage of GIMME is that
it can re-enable flux associated with false negative values in inactive reactions and
record consistency between gene expression data and the predicted flux distribution
for a given objective [98]. Gene inactivation moderated by metabolism, metabolomics
and expression (GIM3E), is an extended version of GIMME which also incorporates
metabolomic data in the form of turnover metabolites added as products to each reac-
tion, along with a corresponding sink reaction [99]. This allows for the computation
of turnover flux ranges for metabolites.
Tissue-specific gene and protein expression values can be integrated into genome-
scale metabolic models accounting for different metabolic objectives at the cellular
level [100], in order to extract information regarding the uptake and secretion of
metabolites by specific tissue and cell-types. For this, tissue-specific variations in
enzyme expression levels are used to inform the likelihood of enzymes supporting
flux in their associated reactions by categorising gene-to-reaction mapping for each
reaction in the model corresponding to the level of gene expression (i.e. high, moder-
ate or low expression). Subsequently, fluxes corresponding to high gene expression
are maximised and those corresponding to low gene expression are minimised when
solving a mixed-integer linear program [101]. This process has been developed into
the Integrative Metabolic Analysis Tool (iMAT) [102], which displays the most
likely predicted metabolic fluxes corresponding to reactions in metabolic models.
This tool enables the definition of a biological objective to be dependent on the
requirements of each cell rather than the entire organism. An extension of iMAT
known as the exploration of alternative metabolic optima (EXAMO) enables the
design of condition-specific metabolic models for human tissues [103].
Similarly, the integrative network inference for tissues (INIT) algorithm uses tissue-
specific information collected from the Human Protein Atlas to help incorporate
transcriptomic and proteomic data into a genome-scale model and produce cell-type
specific metabolic networks [104]. This data forms the input for a mixed-integer linear
problem, which modifies the steady-state condition by setting a small positive net
accumulation rate for internal metabolites [105]. Net productions of these metabolites
are assigned positive weights, corresponding to arbitrary scores for the level of protein
expression. An updated version of INIT known as the task-driven integrative network
inference for tissues (tINIT) was devised to identify structural analogs to metabolites
(so-called ‘antimetabolites’) and a core set of metabolic tasks to be included in the
model [106]. tINIT prevents simultaneous flux in reversible reactions and allows the
user to decide whether net production of all metabolites should be considered. The
algorithm for metabolic adjustment by differential expression (MADE) compares the
fold changes of gene expression values between conditions to intuitively predict the
most consistent and statistically-significant metabolic adjustments [107]. The fold
changes are expressed as a series of binary expression states, for which differences
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between successive states most closely mirror corresponding differences in the mean
expression levels.
Valve-based methods for omic integration. Unlike switch-based methods, valve-
based algorithms reduce the activity of lowly expressed genes by adjusting the upper
and lower bounds for their corresponding reactions. This is usually proportional
to the normalised expression of the genes associated with those reactions before
performing FBA [95]. Such methods include E-flux [108], E-flux2 [109], METRADE
[110], FALCON [111] and PROM [79]. For valve-based methods, gene expression
data is not discretised as in switch-based methods. Data from methods that treat
gene expression as relative as opposed to absolute are more indicative of protein
concentrations, as levels of transcription are more comparable across genes [112,
105]. In E-flux, flux boundaries are tightly constrained when gene expression is low
but relaxed when gene expression is high [108]; transcript levels can be used to set
an upper bound for the maximum production of enzymes and therefore constrain all
reaction rates [97]. To improve this formulation, E-flux2 adds minimisation of the
Euclidean norm of the measured flux vector, thus generating a unique solution [109].
Personalised reconstruction of metabolic models (PRIME) creates cell-specific mod-
els incorporating both transcriptomic and phenotypic data, and only modifies the
bounds of a small set of reactions within a pre-defined range [113]. Expression
data-guided flux minimisation (E-Fmin) is similar to GIMME in that it minimises
a sum of fluxes where weights are a function of gene expression level; however,
biomass production is forced to carry non-zero flux (i.e. metabolic activity is not
threshold-dependent) and all reactions are thermodynamically-feasible due to flux
minimisation [114]. FALCON is a novel algorithm that estimates enzyme abundances
using gene-protein-reaction (GPR) rules in the model, thus improving the predictive
capability of models integrated with expression data [111]. Within a multi-omic
model, the metabolic and transcriptomics adaptation estimator (METRADE) con-
structs a Pareto front in order to identify the best trade-off when multiple objectives
are simultaneously optimised [110]. Transcriptomic data comprising gene expression
profiles and codon usage arrays can be mapped to a phenotypic objective space where
each profile is associated with a condition [115]. In this way, the identification of
optimal metabolic phenotypes is facilitated through the concurrent maximisation or
minimisation of multiple metabolic markers and comparison of predicted flux rates
between objectives.
Network pruning. In addition to switch- and valve- based integration methods, there
are also pruning methods such as MBA [116], FASTCORE [117], mCADRE [118]
and OnePrune [72], which only retain a core set of reactions in the metabolic model.
FASTCORMICS is a faster adaptation of FASTCORE which facilitates data integra-
tion by pre-processing and produces multiple metabolic models [119]. Similarly, the
cost optimisation reaction dependency assessment (CORDA) algorithm performs a
four-step dependency assessment before calculating flux whilst minimising cost pro-
duction i.e. utilising as many high confidence reactions as possible and minimising
the involvement of absent reactions [120]. The cost of each reaction in the network is
represented by the addition of a pseudo-metabolite as a product. CORDA is quicker
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to implement than many other pruning methods owing to its use of FBA to calculate
flux.
On the other hand, there are many methods do not fit into the aforementioned
categories (switch/valve/network pruning) as they utilise more unconventional ap-
proaches for omic data integration. Similar to E-flux2, the regularised context-specific
model extraction method (RegrEx) is based on principles of regularised least squares
optimisation by minimising the squared Euclidean distance between fluxes and
experimental data [121] to calculate fluxes which are independent of user-defined
parameters. Instead of assigning expression measurements to individual genes or
reactions, the GC-Flux algorithm splits GPR strings for each reaction into functional
gene complexes to overcome the assumption of proteins catalysing more than one
reaction at a time [122]. Another recent development is the use of the Huber penalty
convex optimisation function (HPCOF) combined with flux minimisation, to achieve
a more accurate prediction of fluxes which are closer to experimentally measured
values [123]. This method introduces continuous gene expression values in the form
of both constraints and target equations, without the need for definition of a biomass
objective function or expression thresholds. A novel method known as omFBA [124]
uses a phenotype-match algorithm to formulate the optimal objective function, i.e.
the function that yields the most accurate estimations of the observed phenotypes.
This objective can be simultaneously correlated with multiple omic data types via
regression analysis to generate a omics-guided objective function, consequently
resulting in a clearer correlation between genotype and phenotype and improved
phenotypic predictions.
Genetic perturbation and objective function selection
Genetic perturbation is an important tool for establishing gene essentiality and
maximising pathway efficiency. Deciding upon the number of gene perturbations to
be performed depends on multiple factors. Choosing to perform single or pairwise
gene perturbations one-by-one may fail to capture the essentiality and function of that
gene as a result of genetic redundancy (i.e. there may be multiple genes encoding the
same function). However, concurrently knocking out multiple genes can cause issues
related to scaling unless coupled with e.g. Shapley value analysis, which assigns a
contribution value to each gene knockout in the system [125]. Synthetic lethality can
be described as the simultaneous inactivation of a set of non-essential genes resulting
in the death of a cell or organism [126]. Knocking out multiple synthetic lethal pairs
for genome-scale metabolic models can help in analysing the structural robustness of
metabolic networks and identifying interdependencies among genes and reactions
[127].
There are numerous algorithms for the detection and analysis of synthetic lethal
pairs. Fast-SL is an algorithm capable of identifying higher order lethal reaction and
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gene sets by taking GPR (gene-protein-reaction) associations into account and vastly
reducing the search space before iterating through the remaining combinations of
genes/reactions [128]. Minimal cut sets can also be regarded as synthetic lethals,
which can be targeted for drug therapies as they constitute essential gene/reaction sets
[129]. The data mining synthetic lethality identification pipeline (DAISY) statistically
infers interactions between synthetic lethals using a combination of approaches: ge-
nomic survival of the fittest (SoF), shRNA-based functional examination and pairwise
gene coexpression [130]. A method for identifying dosage lethality effects (IDLE)
in genome-scale models of cancer metabolism exploits synthetic dosage lethality to
simulate the pairwise knockout of non-essential enzymes via overexpression of the
first gene and underexpression of the second [131].
Flux ratios can be applied as constraints for FBA using the flux balance analysis
with flux ratios (FBrAtio) algorithm, which can be directly implemented into the
stoichiometric matrix of genome-scale metabolic models [132, 133]. In FBrAtio,
multiple enzymes compete for metabolic branch points in the network (known as crit-
ical nodes) [132], which specify how a substrate in the metabolite pool is distributed
between competing reactions; this depends on factors relating to thermodynamics
such as enzyme availability and downstream accumulation of reactive intermediates.
The optimisation of flux ratios for a particular phenotype can be achieved through
partial knockdown, overexpression or total knockout of enzyme-coding genes [132].
As opposed to complete knockouts, performing gene over-expression or partial
knockdown may prove to be useful for targeted reduction of expression levels.
The minimisation of metabolic adjustment (MOMA) method relaxes the assumption
of optimal growth flux for gene deletions by solving a quadratic problem to optimise
distance minimisation in flux space [134]. This is because the minimal response to
the perturbation is considered to be a more accurate estimate of the true flux state in
the mutant [135]. Initially, the flux distribution for the mutant remains as close as
possible to optimal flux for the wild-type and deviates to form a sub-optimal flux
distribution between that of the wild-type and mutant. In this way, MOMA is able to
predict phenotypic outcomes following knockouts more precisely than FBA.
Using a mechanistic model of reaction rates, integrative omics metabolic analysis
(IOMA) also solves a quadratic problem to deliver kinetically-derived estimations of
flux following genetic perturbation [136]. This is possible through integrating quanti-
tative proteomic and metabolomic data into the model, which improves performance
when compared to MOMA. Similarly, regulatory on/off minimisation (ROOM) min-
imises the number of significant flux changes following knockouts with respect to
the wild type [137]. This is achieved through redirecting flux through alternative
pathways following knockout.
Many gene perturbation experiments simulate knockouts under the assumption
that there is no downstream effect on gene regulation [112]. In the RELATCH
method, the principle of relative optimality is applied to predict how cells adapt to
perturbations, by minimising relative flux patterns and latent pathway activation with
respect to a reference flux distribution [138]. As strains adapt to their perturbed state,
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they undergo regulatory and metabolic changes, represented by two parameters -
one penalising latent pathway activation and another limiting enzyme contribution
increases in active pathways. In varying environmental conditions, Bayesian factor
modelling can be used to elucidate pathway cross-correlations and identify degrees
of pathway activation [139]. Unconventionally, the REMEP method considers the
impact of perturbations on metabolite as well as flux patterns [140]. This leads to
improved flux predictions for knockout mutants as the structure of cellular regulation
is represented more accurately.
Multi-objective optimisation of metabolic models
It can be difficult to define the single most important objective in a biological
system as there are usually multiple conflicting cellular objectives in addition to
the maximisation of biomass, which is often used as a proxy for growth. Methods
such as Bayesian objective function discrimination can be used for selection of
the most suitable objective function by using a probabilistic approach to compare
multiple objectives [141]. Alternatively, there are methods utilising lexicographic
ordering [142] or calculation of a weighted sum to scalarise multiple objectives
[143]; however, it can be difficult to select weights that elicit a uniform distribution
of Pareto solutions and find solutions in non-convex regions [144, 145, 146]. Thus,
multi-objective optimisation arguably presents the most realistic representation of
metabolic flux in biological systems by considering the contribution of a wide range
of competing objectives. The rest of the section describes the main methods used to
implement multi-objective optimisation in metabolic models.
Multi-objective optimisation can be used to resolve trade-offs between conflicting
metabolic objectives through simulating a series of optimal, non-dominated vectors
f(x) in the multi-dimensional objective space. For such vectors, an improved solution
does not exist for any given objective without sacrificing the performance of another
[110]. This is known as a Pareto front and enables the simultaneous consideration of
multiple conditions and constraints affecting each cellular objective [147]. For exam-
ple, optimisation of the objective function r through maximisation or minimisation
of the vector function f(x) may be carried out respectively as follows:
fi(x)> fi(x∗), ∀ i= 1, ...,r
fi(x)< fi(x∗), ∀ i= 1, ...,r
(2)
where x* constitutes all non-dominated vectors present in the search space, for which
there is no point x such that either of the above statements are satisfied (depending on
whether a maximisation or minimisation is carried out). On the other hand, the non-
linearity of metabolic networks means that there is often concavity or discontinuity
present in Pareto fronts [148]. These issues may be resolved through the use of
multi-objective evolutionary algorithms (MOEAs), through which it is possible
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to obtain the entire set of Pareto-optimal solutions by running the algorithm only
once [149]. Genetic design by multi-objective optimisation (GDMO) [150] employs
MOEAs to find genetic manipulations (in the form of Pareto-optimal solutions) that
simultaneously optimise multiple metabolic objectives.
The most widely used MOEA is NSGA-II [151], which conducts cross-comparisons
between points in the objective space to establish whether a higher value exists
for all objectives. This process is known as non-dominated sorting, as it involves
categorising values in the distribution as either dominated or non-dominated. The
non-dominated values are ordered into a front and the normalised distances between
these points and their nearest neighbours are computed for each front. These are
known as crowding distances and are necessary to preserve diversity (i.e. obtain a
good spread of solutions), but may cause instability if two or more points share the
same fitness values [152]. A sphere-excluding evolutionary algorithm (SEEA) has
been proposed for maximising diversity in NSGA-II and preventing convergence at
local optima [153]. Through comparing the non-dominated fronts, it is possible to
establish the prioritisation of objectives for the production of specific metabolites.
In the interests of metabolic engineering, it is often useful to ascertain which knock-
outs would optimise the production of a specific metabolite. Commonly used for
strain improvement in metabolic engineering, OptKnock is a computational method
that identifies and subsequently removes metabolic reactions capable of uncoupling
biomass maximisation from the production of a specific metabolite using a nested
optimisation framework [154]. Cellular transport rates and secretion pathways can
also be used to further constrain this multi-objective model [155]. RobustKnock is
an extension of OptKnock that considers the role of competing pathways in diverting
metabolic flux away from production of the desired metabolite, thus leading to sub-
optimal flux distributions [156]. Therefore, the removal of these competing pathways
and improved knockout strategies result in more robust flux predictions. OptForce
can be used to specify perturbations leading to targeted overproduction of a metabo-
lite [157], with a variant known as k-OptForce which includes kinetic parameters
if available (in the form of kinetic rate laws and metabolite concentrations) [158].
ReacKnock proposes an improved solution to previous methods defining strategies
for deleting reactions, in that the Karush-Kuhn-Tucker (KKT) method is used to
reformulate the problem for single-level optimisation [159]. As well as reaction
deletions, OptStrain provides strategies for reaction addition through identifying
non-native reactions in universal databases that are likely to improve product yields
[160]. Furthermore, SimOptStrain considers gene deletions, addition of non-native
reactions and gene-protein-reaction rules for optimising a given pathway [161]. Other
strategies for gene deletion include genetic design through local search (GDLS) [162],
the cipher of evolutionary design (CiED) [163], simulated annealing (SA) algorithms
and set-based evolutionary algorithms (SEAs) [164].
Linear Physical Programming-Based Flux Balance Analysis (LPPFBA) aims to
prioritise objectives and constraints for a given set of Pareto-optimal solutions, thus
aiding the identification of conflicting objectives and regions of the solution space
that contain feasible optimal fluxes [165]. Comprehensive Polyhedra Enumeration
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Flux Balance Analysis (CoPE-FBA) indicates the topology of the sub-networks
corresponding to optimal flux vectors in polyhedra with an emphasis on vertices of
the solution space [166]. This process can be refined by dividing reversible reactions
(termed linealities) into separate forward and backward reactions, thus simplifying
the optimal solution space for optimisation of more objectives and yielding all
non-decomposable flux routes [167].
Metabolic interactions between species in a microbial community have been simu-
lated with respect to multiple objectives using algorithms such as OptCom, which
provides a framework for the comparison of fitness trade-offs for individual species
against that of the community [168]. Community flux balance analysis (cFBA)
utilises non-linear multi-objective optimisation to build a more complete picture of
metabolic fluxes by predicting biomass abundance as well as metabolite exchanges
with the addition of community-specific constraints [169]. However, only flux dis-
tributions resulting in optimisation of the community growth rate are identified and
the quality of flux predictions obtained using this method is heavily reliant on the
quality of model reconstructions [170]. The community and systems-level interactive
optimisation (CASINO) toolbox has been developed to conduct multi-level opti-
misation and phenotypic prediction for analysis of microbial interactions within a
metabolic model of the human gut [171]. Here, biomass production for individual
species as well as the microbial community as a whole is calculated, starting from a
community matrix defining the topology of all reactions. The microbial community
modeller (MCM) is another such tool where parametric fitting, sensitivity analysis
and statistical evaluation are incorporated into models to assess the metabolic poten-
tial of each species in a community at the cellular level [172]. The computation of
microbial ecosystems in time and space (COMETS) takes spatio-temporal dynamics
into account by simulating time-dependent fluxes on a lattice containing information
about the spatial distribution of microbial species and nutrients within a community;
in addition to interactions, growth and uptake of substrates by different species can
be simulated to examine how intracellular resource allocation is locally optimised by
each species [173].
For multi-objective optimisation in dynamic flux states, changing intra- and extracel-
lular concentrations of metabolites (and their corresponding gene expression values)
can be observed over time using MetDFBA [174], which reduces the number of
parameters for DFBA, thereby improving flux estimations. In this manner, different
objective functions representing various phenotypes can be compared, and objectives
that constrain fluxes corresponding to specific metabolites can be noted so that the
feasible solution space can be further constrained. d-OptCom is a dynamic, multi-
level extension of OptCom through which biomass accumulation and exchange of
metabolites in microbial communities can be examined using dynamic mass balance
equations and substrate uptake kinetics [175]. The AMIGO2 Toolbox reformulates
optimal control problems as dynamic multi-objective optimisation problems, which
can be solved using non-linear programming [176]. To circumvent the difficulties of
acquiring time-course data to generate detailed kinetic models, ensemble modelling
methods utilise steady state phenotypic data (such as flux changes caused by genetic
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perturbations) to specify a set of models which represent the dynamics of a metabolic
system [177]. Ensemble Modeling for Robustness Analysis (EMRA) considers how
to maintain robustness in non-native pathways by building an ensemble of models
linked to the same steady-state flux distribution. Subsequently, a continuation ap-
proach is used to alter kinetic parameters until a bifurcation point is found, where the
steady state disappears [178].
Noninferior set estimation (NISE) has been used to divide the solution space and com-
pute weights for multiple objectives in a multi-objective method for FBA (MOFBA).
MOFBA can (i) generate Pareto curves demonstrating competing metabolic objec-
tives and (ii) compute individual flux distributions for each Pareto optimal solution
[179]. Large scale differential algebraic equation (DAE) solvers can be used to
construct Pareto optimal curves for various perturbations such as heat shock, and
observe where the nominal operating point for the wild type lies with respect to each
curve [180]. There are variations of DAE systems that allow for sensitivity analysis
to examine the rates of changes caused by small perturbations. Usually, sensitivity
analysis examines the effect of changes in the reaction [181], pathway [150] and
species [182] spaces of metabolic models [183]. The recently developed method for
thermodynamics-based metabolite sensitivity analysis (TMSA) ranks metabolites
on their ability to limit solutions to thermodynamically-consistent reactions and
provides information about thermodynamic uncertainty in metabolic networks [184].
ORACLE (optimisation and risk analysis of complex living entities) evaluates quan-
titative uncertainty in kinetic models by sampling metabolite concentrations, and
computing elasticity for enzyme states which represent the displacement of enzymes
from thermodynamic equilibrium [185]. iSCHRUNK extends the ORACLE approach
by including machine-learning classification algorithms to specify enzyme saturation
levels and derive a more feasible population of kinetic models than ORACLE through
achieving better characterisation of the kinetic parameters in the solution space [186].
In the following section, we present a hands-on tutorial for genetic design by multi-
objective optimisation. Although several pipelines are available in Matlab and Python,
this is the first tutorial available in R for multi-objective optimisation of FBA models.
Genetic design by multi-objective optimisation: an R tutorial
This tutorial on genetic design by multi-objective optimisation (GDMO) [150] shows
how a multi-objective genetic optimisation algorithm (in this case, a modification of
NSGA-II [151]) can be used to optimise the trade-off between multiple metabolic
objectives. This is useful both as a tool for metabolic engineering (for example,
when finding the favourable set of nutrients to optimise a microbial strain), and
for quantifying the relationship between the objectives. The flowchart in Figure 2
provides a brief overview of the main stages of GDMO performed in R. Although we
provide an explanation of the code, we suggest the following books for familiarisation
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with the fundamentals of programming in R and evolutionary optimisation methods
[187, 188, 189].
R, Python and Matlab all have good support for metabolic modelling. For a researcher
approaching the field, the primary deciding factor is personal programming language
preference. Performance is largely unrelated to language because the most time
consuming step is optimising the linear optimisation problem, which is performed by
an external linear programming toolkit. We have had particularly good results with
the commercial solver Gurobi and the open source solver GLPK.
(v) NSGA II: Non-dominated
sorting 
 
(vii) Construct plot to view Pareto
front 
load tidyverse, stringr and fbar libraries  
sort and find normalised 
distances for points 
(vi) NSGA II: Find crowding
distance 
Workflow: R Tutorial 
(ii) Read model
(iii) Extract genes from model
(iv) Evaluate model
(i) Install and load R libraries
examine trade-off between biomass 
and synthetic objectives 
evaluate gene-reaction associations 
optimise and fix maximisation of biomass 
optimise maximisation of synthetic objective 
perform cross-comparison of points 
allocate non-dominated points to front 
download and read in model 
make a table containing gene-reaction 
associations 
Fig. 2 A flowchart outlining the main stages of the R tutorial: (i) loading the requisite R libraries for
analysis; (ii) reading the metabolic model into R; (iii) compiling a table that associates a list of genes
extracted from the model with the reactions they are involved in; (iv) evaluating these associations
by checking for the presence of genes in each iteration and performing FBA to obtain estimates of
the biomass and synthetic objectives; (v) implementing a custom version of the NSGA-II algorithm,
which conducts comparisons between points in the flux distribution to establish whether a higher
value exists for all objectives, thus categorising these as dominated and non-dominated, the latter
of which are ordered into a front; (vi) computing crowding distance i.e. the normalised distances
between non-dominated points and their nearest neighbours in each front and dimension; (vii)
viewing the Pareto front, through which it is possible to establish the prioritisation of objectives for
the production of specific metabolites. The full code for this tutorial is provided in the Supplementary
Material, and is downloadable from http://modellingmetabolism.net.
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Loading and preparing a metabolic model are the first steps of any metabolic mod-
elling procedure (see Supplementary Material). Assuming the initial steps have been
carried out, we now describe the evaluation function that we use. In the context of
multi-objective modelling, the evaluation function returns a number of values, each
of which is used as an objective to be optimised. The evaluation function that we use
here has four main stages:
1. The gene-reaction associations (geneAssociation) are evaluated in the
context of which genes are present in this iteration (genome), to give an
activation value, which is an estimate of reaction rate.
2. The activation value is used to alter the upper and lower bounds on reaction
rate (uppbnd and lowbnd), to push reaction rates towards the rate estimates.
3. We conduct a round of FBA, optimising for maximum biomass.
4. We fix the biomass production value to its maximum, by altering the corresponding
uppbnd and lowbnd to be near the flux (+/-1%).
5. With the biomass value fixed, we alter the objective coefficient (obj_coef) to
target optimisation of the synthetic objective (acetate in the example).
The technique of fixing the biomass followed by maximising the synthetic objective
is important because there could still be slack in the model after the first optimisation
stage, which would allow for multiple possible synthetic objective values for a given
biomass value and genome. This slack must be removed by a second optimisation
round since we wish to have a correct and consistent estimate of the synthetic
objective.
evaluation_function <- function(genome){
res <- model %>%
mutate(activation = fbar::gene_eval(expressions = geneAssociation,
genes = names(genome),
presences = genome
),
activation = coalesce(activation, 1),
uppbnd = pmin(uppbnd, 1000*activation+0.1),
lowbnd = pmax(lowbnd, -1000*activation-0.1)) %>%
fbar::find_fluxes_df(do_minimization = FALSE) %>%
mutate(lowbnd = ifelse(abbreviation=='Biomass_Ecoli_core_w/GAM',
flux*0.99,
lowbnd),
uppbnd = ifelse(abbreviation=='Biomass_Ecoli_core_w/GAM',
flux*1.01,
uppbnd),
obj_coef = 1*(abbreviation=='EX_ac(e)')) %>%
fbar::find_fluxes_df(do_minimization = FALSE)
return(list(bm = filter(res, abbreviation=='Biomass_Ecoli_core_w/GAM')$flux,
synth = filter(res, abbreviation=='EX_ac(e)')$flux))
}
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Before proceeding with the genetic optimisation portion of the procedure, we need
to describe two helper functions to our slightly modified form of NSGA-II, termed
non_dom_sort and crowding_distance. Note that the following descrip-
tions refer to the full code provided in the complete tutorial, available as Supplemen-
tary Material.
Non-domination sorting is the first stage of the selection procedure in NSGA-II. It
sorts the points by multiple objectives to Pareto, or non-dominated fronts. These
fronts are designed such that for every point in a front, there is no point in the same
front or another front with a higher number such that the second point is better than
the first in every objective (see Equation 2). This is calculated as follows:
1. We compare every point against every other point.
2. For each point (x), we see if there exists any second point (y) that has a higher
value in all objectives. Where such a second point exists, we term the original
point ‘dominated’.
3. We find the set of points that have no dominating point, and term this the first
non-dominated front. When two points are identical, they are both assigned to the
same front.
4. We repeat this procedure, but ignore points in the first non-dominated front to find
the second non-dominated front, and so on.
The second part of the NSGA-II evaluation procedure is finding the crowding distance.
This is used to break ties between points in the same non-dominated front. For each
front and for each dimension, this function sorts the points into order along the
dimension, and finds the normalised distance between the proceeding point and
succeeding point. These values are summed up across each dimension to find the
value for the point.
The following code is the genetic loop of the algorithm. It is explained by code
comments, but follows a normal pattern of evaluating, sorting, selecting from and
mutating the population. The genetic algorithm used here is a modified version of
NSGA-II [151], with a population of 200 individuals and carrying out 500 iterations.
Inside the loop, the steps are as follows:
1. Evaluate all genomes: first, we use the evaluation function on each genome to find
the resulting biomass and synthetic fluxes.
2. Round the results: this is a useful tool to help the NSGA-II procedure by regarding
very similar results as identical, encouraging more variety in the results set.
3. Label the results: labelling is required so that we can identify them after non-
dominance sorting.
4. Shuffle: shuffling the results is important because inevitably, some points will be
completely identical, and we want to choose one at random in this case, rather
than always pick the same result.
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5. Find the non-dominated fronts: assign a front number to each point, such that
points with a lower front number are strictly superior to those with a higher one.
6. Find the crowding distance: select for points with more variety.
7. Sort by front, breaking ties by crowding distance: there are normally multiple
points in each front, so the continuous crowding distance value is required to
choose between these.
8. Keep the best half of the population: using the label assigned earlier.
9. Sample parents from population: use random sampling with replacement to find
which members of the population are used as a basis for new members.
10. Mutate parents to create offspring: add new members to the population by flipping
2% of the genes in the parents.
11. Combine the offspring and parent populations: build the new population and
repeat.
start_genome <- set_names(rep_along(genes_in_model, TRUE), genes_in_model)
pop <- list(start_genome)
popsize = 200
generations = 500
for(i in 1:generations){
results <- map_df(pop, evaluation_function) %>% # Evaluate all the genomes
mutate(bm=signif(bm), synth=signif(synth)) %>% # Round results
mutate(id = 1:n()) %>% # label the results
sample_frac() %>% # Shuffle
non_dom_sort() %>% # Find the non-dominated fronts
crowding_distance() %>% # Find the crowding distances
arrange(front, desc(crowding)) # Sort by front, breaking ties by crowding distance
selected <- results %>%
filter(row_number() <= popsize/2) %>% # Keep the best half of the population
getElement('id')
kept_pop <- pop[selected]
altered_pop <- kept_pop %>%
sample(popsize-length(selected), TRUE) %>% # Sample parents from population
map(function(genome){
xor(genome, runif(length(genome))>0.98) # Mutate parents to create offspring
})
pop <- unique(c(kept_pop, altered_pop)) # Combine the offspring and parent populations
}
Once we have a results set, we can construct a plot like Figure 3 to view the non-
dominated fronts. We can see how the first front describes the trade-off between
biomass and the synthetic objective, with the lines showing the dominated area (to the
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bottom left). This shows that even with a small population and number of iterations
we can see three high quality tradeoff points between the synthetic objective and
biomass production, with biomass values of around 0.75, 0.63 and 0.38 h−1, and
corresponding synthetic values of 6, 11 and 14 mmol h−1 gDW−1.
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Fig. 3 Plot of a sample Pareto front showing the trade-off between the biomass (x-axis, h−1) and
the synthetic objective (y-axis, mmol h−1 gDW−1). The area underlying each of the ten fronts of
non-dominated points represents the number of metabolic configurations in the solution space that
are supported when the objectives are maximised (or minimised).
Perspective: integration with multi-view machine learning
approaches
Multi-view learning can be described as a sub-division of machine learning methods
that aims to merge different aspects of a common problem in a single setting. It is
based on principles of maximising the consensus between different viewpoints whilst
offsetting the limitations of each view through complementation with the other views
[190]. It is evident that this approach is highly applicable to the context of poly-omic
data integration in genome scale metabolic models, owing to the interdependencies
and correlations between all types of poly-omic data. At the very least, genomics,
transcriptomics and proteomics are inextricably linked by the central dogma of
molecular biology [191].
However, as omic types significantly differ in their scale and structure, the data is
classed as heterogeneous and several normalisation measures would be required prior
to mapping each omic as a layer in the metabolic model. Integration following the
simultaneous analysis of multiple data types (known as meta-dimensional analysis)
may be preceded by directly concatenating single sample matrices into one large ma-
trix, transforming samples into intermediate graph or kernel matrices, or generating
multiple models using different data types as training sets [192].
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Data integration can be performed at an early, intermediate or late stage, depending
on the nature of the data and the learning algorithm used. Early integration allows
for the creation of a large pool of data before processing. Intermediate integration
involves condensing each view into a similarity matrix with pairwise comparisons
before a learning algorithm is applied. Late integration provides the opportunity
to select the most suitable learning algorithm for each omic before merging data,
comparing analyses between omics and linking patterns found in each omic [193]. As
early integration increases data dimensionality rather than reducing it, intermediate
or late integration would be preferred in this context to avoid introducing noise and
decreasing performance prior to data transformation.
Methods such as clustering and multiple kernel learning have successfully been
implemented in cancer sub-typing on the basis of shared molecular characteristics,
and are ideal for classifying unsupervised data into groups to detect underlying
associations where there is little information available [194, 195]. K-means is a
traditional clustering algorithm that finds the number of clusters minimising the
sum of the squared Euclidean distances between each observation and its respective
cluster mean [196]. The algorithm starts by selecting k random points in the dataset
(termed cluster centroids), which define the groups that the remaining data points are
assigned to. The centroids are then moved to the averages computed in each group,
and the process is repeated until distinctive clusters are formed. A number of flaws
can be identified when this process is applied to multi-view learning. The primary
concern is that of a lack of consideration of the importance of each individual view,
as well as the differences between multiple views.
To address these issues, a bi-level variant of k-means clustering known as Tw-k-means
was established, which added simultaneous weighting of both views and individual
variables. This resulted in easier identification of the importance of variables and
views, as well as in a decrease in the effect of low quality views and noise [197].
An alternative multi-view clustering approach known as iCluster [198] has been
developed to model cancer subtypes from the Cancer Genome Atlas. In iCluster,
cancer subtypes are considered as latent variables, which could be estimated by
taking differences between views into account when partitioning multidimensional
data into disparate groups. If a clustering algorithm is chosen for the partitioning of
poly-omic data, it is important to note that the clusters of genes or metabolites may
vary depending on the condition modelled. Integration by matrix factorisation (IMF)
compiles clusters into matrices, which are factorised to assess the contribution of
each separate cluster to each view, as well as the overall contribution of each view
[199].
Multiple kernel learning transforms data structures into kernel matrices and optimises
weight vectors that linearly combine these matrices to generate a unified kernel matrix.
This facilitates the intermediate integration of data from different views, irrespective
of the number of features utilised [195]. Another kernel-based technique known as
similarity network fusion (SNF) [200] separately combines samples within each type
of data to form individual networks. Such networks are iteratively integrated into a
large, comprehensive network, mapped to the feature space in a non-linear fashion
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and used to assess the amount of information of each data type in explaining any
similarity observed between the samples. In a modified version of similarity network
fusion [201], a bias layer was introduced between omic layers to account for the
varying quality of metabolic reconstructions and therefore assign larger weights to
omic layers that contributed more to the phenotype.
A support vector machine (SVM) is a supervised learning technique that, given a set
of training examples, determines the optimal hyperplane to separate classes in the
feature space whilst maximising the distance between samples of different classes
[202]. Linear models such as SVMs or the least absolute shrinkage and selection
operator (LASSO) can be treated as classification or regression problems respectively
for performing feature concatenation with heterogeneous features, such as those
found in poly-omic data [203].
Decision tree-based methods are highly intuitive and allow the analysis of both
continuous and discrete features in the same model without the need for data normali-
sation. However, the high dimensionality of poly-omic datasets would make decision
trees prone to noise and overfitting (especially if there are an insufficient number of
features) [203]. This can be overcome by utilising ensemble learning methods such
as random forest, which selects features at random as it constructs a decision tree.
If a classification approach is taken, the most popular class is voted for following
the generation of multiple trees; if the regression approach is taken, outputs from the
multiple trees are averaged [204].
Feature selection utilises the minimum information necessary to classify key features
and could prove useful in identifying the most significant trends in poly-omic datasets.
Fortino et al. [205] have described a multivariate discovery process using “fuzzy
patterns” to discretise and label gene expression data for the selection of the most
relevant features. A random forest algorithm was then used to rank features in order
of their usefulness, and to improve the stability and accuracy of data. A variation
of this method has been used to implement feature selection in the integration of
metabolomic, lipidomic and clinical data for the study of obesity and metabolic
syndrome [206].
A number of Bayesian methods could also be applied to poly-omic data integration,
such as Gaussian mixture models and Latent Dirichlet Allocation (LDA). Angione
et al. [139] incorporated matrix factorisation into a Bayesian hierarchical model
using Gaussian Markov Random Fields (GMRFs). This approach led to inferring
cross-correlations between pathways in a metabolic network, and to prediction
of pathway activation profiles as a result of bacterial responses to environmental
conditions. Using a Bayesian method, predefined reaction-pathway memberships
were used to model the prior distribution that was multiplied by the likelihood of
observations to obtain the posterior distribution, which was subsequently used to
infer model predictions. This approach serves to facilitate the observation of links
between reactions, pathways and conditions, which can in turn help to interpret the
consequences of metabolic flux variations and, consequently, the biological system
as a whole. LDA has yet to be applied to poly-omic integration but has potential
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because of its efficacy in organising unsupervised data from a mixture of clusters
[207].
Conclusion
In this work, we have surveyed the principal methods available for constraint-based
modelling and omic integration. We have presented these in the form of a ‘forest’,
also available in interactive version at http://modellingmetabolism.net where it will
be updated periodically. As an up-to-date classification of available methods, we
believe that this will prove to be a useful resource for prospective modellers. We
have also provided the first tutorial in R for multi-objective optimisation of metabolic
models.
We envisage that a late integration approach can be used to test the suitability of
various multi-view learning algorithms for each omic dataset used in the integra-
tion process, depending on the structure of the data. For example, a clustering
algorithm may be chosen for mapping microarray or RNA sequencing data onto a
metabolic model. Likewise, a SVM may be chosen for mapping protein data or post-
translational modifications. Finally, feature selection may be employed to identify
the most distinctive features across both of these omic layers, as a whole.
In the near future, the integration of multi-view machine learning in metabolic mod-
elling is likely to grow in parallel with the rapid advancement of high-throughput
omic technologies. With the increase in the number of omic layers, existing algo-
rithms will continue to be extended. However, we believe a one-size-fits-all approach
is not the most effective way of tackling a multi-omic genome-scale problem. Given
the intrinsic differences between omic layers, we envisage specific algorithms de-
signed only for the analysis of each layer. When required, a global prediction can then
be achieved through methods for aggregation of layers, such as those successfully
employed in multilayer network theory.
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Full code and details of the R tutorial on genetic design by
multi-objective optimisation
Here we present and describe the full code needed to conduct Genetic Design by
Multi-Objective Optimisation in R. Note that here, in addition to the functionality
described in the main text, we here cover the boilerplate code associated with loading
libraries and preparing data, and the more length aspects of the NSGA-II procedure.
First, we need to load the appropriate libraries:
• tidyverse is a bundle of generic utilities;
• stringr is a string manipulation utility installed alongside tidyverse;
• fbar is a library for flux balance analysis;
library(tidyverse)
library(stringr)
library(fbar)
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This code block downloads and reads in a model, then extracts the list of genes from
the model. The model takes the form of a tabular list of reactions.
model <- read_tsv('https://git.io/v1YsM',
col_types = c('cccdddc'))
genes_in_model <- model$geneAssociation %>%
str_split('[()|& ]+') %>%
flatten_chr() %>%
discard(is.na) %>%
discard(~ str_length(.x)==0)
The evaluation function is where the actual metabolic simulations are performed.
This has four main stages:
1. The gene-reaction associations (geneAssociation) are evaluated in the
context of which genes are present in this iteration (genome), to give an
activation value, which is an estimate of reaction rate.
2. The activation value is used to alter the upper and lower bounds on reaction
rate (uppbnd and lowbnd), to push reaction rates towards the rate estimates.
3. We conduct a round of FBA, optimising for maximum biomass.
4. We fix the biomass production value to its maximum by altering the corresponding
uppbnd and lowbnd to be near the flux (+/-1%).
5. With the biomass value fixed, we alter the objective coefficient (obj_coef) to
target optimisation of the synthetic objective.
The technique of fixing the biomass followed by maximising the synthetic objective
is important because there could still be slack in the model after the first optimisation
stage, and we wish to have a reliable estimate of the synthetic objective.
evaluation_function <- function(genome){
res <- model %>%
mutate(activation = fbar::gene_eval(expressions = geneAssociation,
genes = names(genome),
presences = genome
),
activation = coalesce(activation, 1),
uppbnd = pmin(uppbnd, 1000*activation+0.1),
lowbnd = pmax(lowbnd, -1000*activation-0.1)) %>%
fbar::find_fluxes_df(do_minimization = FALSE) %>%
mutate(lowbnd = ifelse(abbreviation=='Biomass_Ecoli_core_w/GAM',
flux*0.99,
lowbnd),
uppbnd = ifelse(abbreviation=='Biomass_Ecoli_core_w/GAM',
flux*1.01,
uppbnd),
obj_coef = 1*(abbreviation=='EX_ac(e)')) %>%
fbar::find_fluxes_df(do_minimization = FALSE)
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return(list(bm = filter(res, abbreviation=='Biomass_Ecoli_core_w/GAM')$flux,
synth = filter(res, abbreviation=='EX_ac(e)')$flux))
}
Non-domination sorting is the first stage of the selection procedure in NSGA-II. The
code might seem quite opaque, but the idea is as follows:
1. We perform an inner_join in order to compare every point against every other
point.
2. For each point (id.x), we see if there exists any second point (id.y) that has
a higher value in all objectives. Where such a second point exists, we term the
original point ‘dominated’.
3. We find the set of points that have no dominating point, and term this the first
non-dominated front.
4. We repeat this procedure, but ignore points in the first non-dominated front to find
the second non-dominated front, and so on.
non_dom_sort <- function(input){
input_long <- input %>%
gather(property, value, -id) %>%
mutate(front=NA)
currentfront <- 1
while(any(is.na(input_long$front))){
input_long <- input_long %>%
inner_join(.,., by='property') %>%
group_by(id.x,id.y) %>%
mutate(dominance = ifelse(all(value.x>=value.y),
'xdomy',
ifelse(all(value.y>=value.x),
'ydomx',
'nondom'
)
)
) %>%
group_by(id.x) %>%
mutate(front = ifelse(all(dominance[is.na(front.y)] %in% c('xdomy', 'nondom')),
pmin(currentfront, front.x, na.rm=TRUE),
NA
)
) %>%
group_by(id = id.x, property = property, front, value = value.x) %>%
summarise
currentfront <- currentfront + 1
}
return(
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input_long %>%
spread(property, value)
)
}
The second part of the NSGA-II evaluation procedure is finding the crowding distance.
This is used to break ties between points in the same non-dominated front. For each
front and for each dimension, this function sorts the points into order along the
dimension, and finds the normalised distance between the proceeding point and
succeeding point. These values are summed up across each dimension to find the
value for the point.
crowding_distance <- function(input){
return(
input %>%
gather(property, value, -id, -front) %>%
group_by(front, property) %>%
arrange(value) %>%
mutate(crowding = (lead(value)-lag(value))/(max(value)-min(value)),
crowding = ifelse(is.na(crowding),Inf, crowding)) %>%
group_by(id) %>%
mutate(crowding = sum(crowding)) %>%
spread(property, value)
)
}
The following code is the genetic loop of the algorithm. It is explained by code
comments, but follows a normal pattern of evaluating, sorting, selecting from and
mutating the population. The genetic algorithm used here is a modified version of
NSGA-II [151], with a population of 200 individuals and carrying out 500 iterations.
start_genome <- set_names(rep_along(genes_in_model, TRUE), genes_in_model)
pop <- list(start_genome)
popsize = 200
generations = 500
pb <- txtProgressBar(max=generations, style=3)
for(i in 1:generations){
setTxtProgressBar(pb, i)
results <- map_df(pop, evaluation_function) %>% # Evaluate all the genomes
mutate(bm=signif(bm), synth=signif(synth)) %>% # Round results
mutate(id = 1:n()) %>% # label the results
sample_frac() %>% # Shuffle
non_dom_sort() %>% # Find the non-dominated fronts
crowding_distance() %>% # Find the crowding distances
arrange(front, desc(crowding)) # Sort by front, breaking ties by crowding distance
selected <- results %>%
filter(row_number() <= popsize/2) %>% # Keep the best half of the population
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getElement('id')
kept_pop <- pop[selected]
altered_pop <- kept_pop %>%
sample(popsize-length(selected), TRUE) %>% # Sample parents from population
map(function(genome){
xor(genome, runif(length(genome))>0.98) # Mutate parents to create offspring
})
pop <- unique(c(kept_pop, altered_pop)) # Combine the offspring and parent populations
}
Once we have a results set, we can construct a plot to view the non-dominated
fronts. We can see how the first front describes the trade-off between biomass and the
synthetic objective, with the lines showing the dominated area (to the bottom left).
pop %>%
arrange(desc(front)) %>%
ggplot(aes(x=bm, y=synth, colour=factor(front))) +
geom_point() + geom_step(direction='vh', alpha=0.5) +
theme_bw()
